Targeted therapy involves drugs designed to specifically target cancer cells' unique genetic markers or specific proteins involved in cancer growth and survival. This approach aims to minimize damage to normal cells, thus reducing side effects compared to traditional chemotherapy. Examples include tyrosine kinase inhibitors and monoclonal antibodies. Targeted therapy can be used alone or in combination with other treatments to improve outcomes.
